Continue to site >
Trending ETFs

Name

As of 12/24/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

$105.59

$1.18 B

0.34%

$0.36

0.60%

Vitals

YTD Return

2.4%

1 yr return

3.1%

3 Yr Avg Return

-4.9%

5 Yr Avg Return

4.6%

Net Assets

$1.18 B

Holdings in Top 10

22.9%

52 WEEK LOW AND HIGH

$105.4
$101.59
$113.83

Expenses

OPERATING FEES

Expense Ratio 0.60%

SALES FEES

Front Load N/A

Deferred Load N/A

TRADING FEES

Turnover 103.00%

Redemption Fee N/A


Min Investment

Standard (Taxable)

N/A

IRA

N/A


Fund Classification

Fund Type

Exchange Traded Fund


Name

As of 12/24/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

$105.59

$1.18 B

0.34%

$0.36

0.60%

FXH - Profile

Distributions

  • YTD Total Return 2.4%
  • 3 Yr Annualized Total Return -4.9%
  • 5 Yr Annualized Total Return 4.6%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio -0.14%
DIVIDENDS
  • Dividend Yield 0.3%
  • Dividend Distribution Frequency Quarterly

Fund Details

  • Legal Name
    First Trust Health Care AlphaDEX Fund
  • Fund Family Name
    First Trust Advisors L.P.
  • Inception Date
    May 08, 2007
  • Shares Outstanding
    13350002
  • Share Class
    N/A
  • Currency
    USD
  • Domiciled Country
    US
  • Manager
    Roger Testin

Fund Description

The Fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the Index. The Fund, using an “indexing” investment approach, attempts to replicate, before fees and expenses, the performance of the Index. The Index is part of the “StrataQuant® Series,” a family of custom enhanced indices developed, maintained and owned by ICE Data Indices, LLC or its affiliates (“IDI” or the “Index Provider”). The Index Provider reserves the right to, at any time, change the number of stocks comprising the Index by adding or deleting one or more stocks, or replacing one or more stocks contained in the Index with one or more substitute stocks of its choice, if in the Index Provider’s discretion, such addition, deletion or substitution is necessary or appropriate to maintain the quality and/or character of the Index. According to the Index Provider, the Index is a modified, equal-dollar weighted index designed to objectively identify and select stocks from the Russell 1000® Index in the health care sector that have the potential for greater capital appreciation. The Index uses the AlphaDEX® selection methodology which aims to select securities that may generate positive alpha, or risk-adjusted returns, relative to traditional indices. Alpha is an indication of how much an investment outperforms or underperforms on a risk-adjusted basis relative to its benchmark. The Russell 1000® Index consists of approximately 1,000 of the largest stocks within the Russell 3000® Index. The Russell 3000® Index is constructed to represent approximately 98% of the investable U.S. equity market. According to the Index Provider, security selection for the Index will be conducted in the following manner: 1.The selection universe for the Index begins with all stocks in the Russell 1000® Index that meet the Index Provider’s share class and liquidity screens. 2.The stocks in the selection universe are ranked on both growth and value factors. Each stock is classified as either a value stock, a growth stock or a combination of growth and value, as determined by the Index Provider. A stock classified as a value stock will receive its value rank as its “selection score” and a stock classified as a growth stock will receive its growth rank as its “selection score.” A stock classified as a combination of growth and value will receive the better of the two scores. 3.The selection universe is then divided into respective sectors as defined by the Index Provider. The component stocks contained in the sector for which the Fund is named are ranked according to their selection score from step 2. 4.The number of “selected stocks” for the relevant sector will be the greater of the top 75% of securities from step 3 or 40 stocks. The selected stocks are then split into quintiles based on their selection score, with higher scoring quintiles receiving a greater weight in the Index. The Index is reconstituted and rebalanced quarterly and the Fund will make corresponding changes to its portfolio shortly after the Index changes are made public. The Index’s quarterly rebalance and reconstitution schedule may cause the Fund to experience a higher rate of portfolio turnover. The Fund will be concentrated in an industry or a group of industries to the extent that the Index is so concentrated. As of October 31, 2024, the Index was composed of 78 securities with a market capitalization range of $1.94 billion to $746.2 billion. As of October 31, 2024, the Fund had significant investments in health care companies. The Fund's investments will change as the Index changes and, as a result, the Fund may have significant investments in jurisdictions or investment sectors that it may not have had as of October 31, 2024. To the extent the Fund invests a significant portion of its assets in a given jurisdiction or investment sector, the Fund may be exposed to the risks associated with that jurisdiction or investment sector.
Read More

FXH - Performance

Return Ranking - Trailing

Period FXH Return Category Return Low Category Return High Rank in Category (%)
YTD 2.4% -26.9% 19.0% 55.97%
1 Yr 3.1% -26.9% 19.1% 59.12%
3 Yr -4.9%* -27.9% 7.4% 80.92%
5 Yr 4.6%* -11.3% 11.4% 59.73%
10 Yr 5.8%* -0.6% 12.6% 68.14%

* Annualized

Return Ranking - Calendar

Period FXH Return Category Return Low Category Return High Rank in Category (%)
2023 -4.8% -12.6% 19.0% 91.82%
2022 -12.4% -53.9% 3.2% 46.71%
2021 15.2% -39.6% 24.2% 7.89%
2020 28.0% -13.6% 178.2% 15.44%
2019 22.3% 3.8% 63.8% 36.09%

Total Return Ranking - Trailing

Period FXH Return Category Return Low Category Return High Rank in Category (%)
YTD 2.4% -26.9% 19.0% 55.97%
1 Yr 3.1% -26.9% 19.1% 59.12%
3 Yr -4.9%* -27.9% 7.4% 80.92%
5 Yr 4.6%* -11.3% 11.4% 59.73%
10 Yr 5.8%* -0.6% 12.6% 68.14%

* Annualized

Total Return Ranking - Calendar

Period FXH Return Category Return Low Category Return High Rank in Category (%)
2023 -4.5% -12.6% 19.0% 93.71%
2022 -12.2% -53.9% 3.7% 62.50%
2021 15.2% -33.9% 26.0% 25.00%
2020 28.0% -0.7% 180.6% 35.57%
2019 22.3% 4.6% 63.8% 73.68%

FXH - Holdings

Concentration Analysis

FXH Category Low Category High FXH % Rank
Net Assets 1.18 B 6.43 M 45.7 B 38.99%
Number of Holdings 79 25 430 54.72%
Net Assets in Top 10 269 M 2.55 M 23.9 B 56.60%
Weighting of Top 10 22.91% 18.9% 78.1% 98.11%

Top 10 Holdings

  1. United Therapeutics Corp 2.42%
  2. Premier Inc 2.34%
  3. Roivant Sciences Ltd 2.32%
  4. Insulet Corp 2.31%
  5. ResMed Inc 2.31%
  6. Jazz Pharmaceuticals PLC 2.29%
  7. Alnylam Pharmaceuticals Inc 2.25%
  8. Exelixis Inc 2.23%
  9. Doximity Inc 2.22%
  10. Natera Inc 2.21%

Asset Allocation

Weighting Return Low Return High FXH % Rank
Stocks
99.93% 89.92% 106.13% 7.55%
Cash
0.12% 0.00% 33.01% 88.68%
Preferred Stocks
0.00% 0.00% 7.86% 89.31%
Other
0.00% -22.99% 23.24% 91.19%
Convertible Bonds
0.00% 0.00% 0.37% 84.42%
Bonds
0.00% 0.00% 12.39% 87.42%

Stock Sector Breakdown

Weighting Return Low Return High FXH % Rank
Healthcare
99.61% 59.26% 100.00% 60.39%
Basic Materials
0.39% 0.00% 7.16% 24.03%
Utilities
0.00% 0.00% 0.00% 84.42%
Technology
0.00% 0.00% 22.69% 86.36%
Real Estate
0.00% 0.00% 5.89% 86.36%
Industrials
0.00% 0.00% 7.02% 86.36%
Financial Services
0.00% 0.00% 1.60% 88.96%
Energy
0.00% 0.00% 0.00% 84.42%
Communication Services
0.00% 0.00% 9.11% 84.42%
Consumer Defense
0.00% 0.00% 25.73% 87.66%
Consumer Cyclical
0.00% 0.00% 1.92% 86.36%

Stock Geographic Breakdown

Weighting Return Low Return High FXH % Rank
US
99.93% 61.27% 104.41% 5.66%
Non US
0.00% 0.00% 34.10% 92.45%

FXH - Expenses

Operational Fees

FXH Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 0.60% 0.08% 4.48% 82.39%
Management Fee 0.50% 0.03% 1.25% 16.98%
12b-1 Fee 0.00% 0.00% 1.00% 10.39%
Administrative Fee N/A 0.03% 0.25% N/A

Sales Fees

FXH Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 3.50% 5.75% N/A
Deferred Load N/A 1.00% 1.00% N/A

Trading Fees

FXH Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 1.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

FXH Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 103.00% 0.00% 238.00% 94.07%

FXH - Distributions

Dividend Yield Analysis

FXH Category Low Category High FXH % Rank
Dividend Yield 0.34% 0.00% 6.24% 31.45%

Dividend Distribution Analysis

FXH Category Low Category High Category Mod
Dividend Distribution Frequency Quarterly Annual Annual Annual

Net Income Ratio Analysis

FXH Category Low Category High FXH % Rank
Net Income Ratio -0.14% -2.54% 1.85% 44.74%

Capital Gain Distribution Analysis

FXH Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Annually Annually

Distributions History

View More +

FXH - Fund Manager Analysis

Managers

Roger Testin


Start Date

Tenure

Tenure Rank

May 08, 2007

15.07

15.1%

Roger F. Testin, CFA, was born in 1966. Mr. Testin earned a B.S. in Accounting from the University of Illinois and has an MBA in Finance from the University of Chicago. He has been with First Trust Advisors L.P. since 2001 and he is a Portfolio Manager and Senior Vice President. As Product Manager for the VA’s, SMA’s and International Managed Products, Mr. Testin shall be responsible for the daily implementation and execution of the strategies for these product vehicles on behalf of the Investment Committee.

Stan Ueland


Start Date

Tenure

Tenure Rank

May 08, 2007

15.07

15.1%

Mr. Ueland joined First Trust Advisors as a Vice President in August 2005 and has been a Senior Vice President of First Trust and FTP since September 2012. At First Trust, he plays an important role in executing the investment strategies of each portfolio of exchange-traded funds advised by First Trust. Before joining First Trust, he was vice president of sales at BondWave LLC from May 2004 through August 2005, an account executive for Mina Capital Management LLC and Samaritan Asset Management LLC from January 2003 through May 2004, and a sales consultant at Oracle Corporation from January 1997 through January 2003.

Daniel Lindquist


Start Date

Tenure

Tenure Rank

May 08, 2007

15.07

15.1%

Daniel J. Lindquist, CFA, was born in 1970. Mr. Lindquist earned a B.A. in Business Economics from Wheaton College and has an MBA in Finance from the University of Chicago. He has been with First Trust Advisors L.P. since 2004 and is a Managing Director. Mr. Lindquist is the Chairman of the Investment Committee and is responsible for the overall supervision of the Separate Managed Accounts.

Jon Erickson


Start Date

Tenure

Tenure Rank

May 08, 2007

15.07

15.1%

Jon C. Erickson, CFA, was born in 1966. Mr. Erickson earned a B.S. in Computer Science from the University of Illinois and has an MBA from the University of Illinois in Finance. He has been with First Trust Advisors L.P. since 1994 and he is a Portfolio Manager and Senior Vice President. As the head of FTA’s Equity Research Group, Mr. Erickson shall be responsible for determining the securities to be purchased and sold by Funds that do not utilize quantitative investment strategies on behalf of the Investment Committee.

David McGarel


Start Date

Tenure

Tenure Rank

May 08, 2007

15.07

15.1%

David G. McGarel, CFA, was born in 1966. Mr. McGarel earned a B.S. in Accounting from the University of Notre Dame. He has been with First Trust Advisors L.P. since 1997 and he is a Managing Director, Chief Operating Officer and the Chief Investment Officer. As head of FTA’s Strategy Research Group, Mr. McGarel shall be responsible for developing and implementing quantitative investment strategies for those Funds that have investment policies that require them to follow such strategies, on behalf of the Investment Committee.

Chris Peterson


Start Date

Tenure

Tenure Rank

Mar 18, 2016

6.21

6.2%

Chris A. Peterson, CFA was born in 1975. Mr. Peterson earned a B.S in Finance from Bradley University and has an MBA from the University of Chicago Booth School of Business with concentrations in Analytic Finance & Accounting. He has been with First Trust Advisors L.P. since 2000. As head of FTA’s Portfolio Advisor’s Strategy Research Group, Mr. Peterson shall be responsible for developing and implementing quantitative equity strategies on behalf of the Investment Committee.

Erik Russo


Start Date

Tenure

Tenure Rank

Dec 31, 2020

1.41

1.4%

Mr. Russo is a Vice President of First Trust. He is responsible for implementing the investment strategies of each portfolio of exchange-traded funds advised by First Trust in his role as a Portfolio Manager. Mr. Russo joined First Trust in January of 2010.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.02 24.72 7.88 0.25